Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.49% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CPIX · Mar 31, 2024
CUMBERLAND PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-24-022658General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-25.14% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-7.88% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
50.93% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
81.46% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-22.00% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
13.63% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
0.93% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History61 statesSelf-history eligible
Sep 30, 20217/7 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20264/4 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.71%
- Current
- 0.49%
- Delta
- -0.22%
- Previous
- 15.41%
- Current
- -25.14%
- Delta
- -40.55%
- Previous
- -2.77%
- Current
- -7.88%
- Delta
- -5.11%
- Previous
- 11.65%
- Current
- 50.93%
- Delta
- 39.27%
- Previous
- 84.66%
- Current
- 81.46%
- Delta
- -3.20%
- Previous
- -24.16%
- Current
- -22.00%
- Delta
- 2.16%
- Previous
- 14.75%
- Current
- 13.63%
- Delta
- -1.12%
- Previous
- 0.92%
- Current
- 0.93%
- Delta
- 0.00%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CPIX Fundamental State →Transitioned To · CPIX Fundamental State →Transitioned To · CPIX CAPEX_INTENSITY_DECREASED →Transitioned To · CPIX CASH_GENERATION_DECREASED →Transitioned To · CPIX GROWTH_DECREASED →Transitioned To · CPIX INVENTORY_PRESSURE_INCREASED →Transitioned To · CPIX MARGIN_DECREASED →Transitioned To · CPIX PROFITABILITY_INCREASED →Transitioned To · CPIX R_AND_D_INTENSITY_DECREASED →Transitioned To · CPIX SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.